PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $82,000 | – | 20,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $40,639,000 | 22.88% |
| Abingworth LLP | 1,301,413 | $24,701,000 | 14.43% |
| Roumell Asset Management, LLC | 201,845 | $3,835,000 | 7.78% |
| GREAT POINT PARTNERS LLC | 453,878 | $8,624,000 | 3.41% |
| Aisling Capital LLC | 682,680 | $12,971,000 | 2.28% |
| Broadfin Capital, LLC | 530,283 | $10,075,000 | 0.56% |
| Tekla Capital Management LLC | 762,581 | $14,489,000 | 0.52% |
| Baupost Group | 1,544,498 | $29,345,000 | 0.49% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $5,264,000 | 0.47% |
| Lombard Odier Asset Management (USA) Corp | 135,710 | $2,578,000 | 0.22% |